Patent · US Active

Crystalline pharmaceutical

US8058433B2 · kind B2 · utility

0Cited by

4References

39Claims

0Family size

Assignee

Abbott Laboratories · US

Inventors

Daniel A. Dickman · Grayslake, US
Sanjay R. Chemburkar · Gurnee, US
James J. Fort · Midlothian, US
Rodger F. Henry · Park City, US
David Lechuga-Ballesteros · Santa Clara, US
Yuping Niu · Nyack, US
William Porter · Vernon Hills, US

Key dates

Filing date	Oct 2, 2006
Grant date	Nov 15, 2011
Priority date	—
Expiry date	Aug 10, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

New crystalline forms of lopinavir are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.